Skip to main content

Table 3 mRNA levels.

From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma

  Patients with asthma Control subjects
ADAM-8 0.396 ± 0.042a 0.080 ±0.007
ADAM-9 0.677 ± 0.018a 0.617 ±0.013
ADAM-10 0.497 ± 0.016 0.547 ± 0.015
ADAM-12 0.145 ±0.012a 0.090 ±0.011
ADAM-15 0.684 ±0.019 0.637 ± 0.022
ADAM-17 1.127 ± 0.024 1.113 ± 0.026
ADAMTS-1 0.184 ±0.021a 0.273 ±0.023
ADAMTS-15 0.188 ± 0.025a 0.522 ±0.029
TIMP-1 0.522 ± 0.037a 0.270 ±0.017
TIMP-3 0.425 ± 0.047a 0.150 ±0.018
RECK 0.457 ± 0.030a 0.644 ± 0.035
  1. mRNA levels were determined in asthmatic and control samples by semiquantitative RT-PCR and normalized to 28S rRNA. Data are expressed in arbitrary units as mean ± SEM. aP < 0.05 vs. control subjects.